AR099581A1 - Compuestos de aminocarbonilcarbamato - Google Patents

Compuestos de aminocarbonilcarbamato

Info

Publication number
AR099581A1
AR099581A1 ARP150100575A ARP150100575A AR099581A1 AR 099581 A1 AR099581 A1 AR 099581A1 AR P150100575 A ARP150100575 A AR P150100575A AR P150100575 A ARP150100575 A AR P150100575A AR 099581 A1 AR099581 A1 AR 099581A1
Authority
AR
Argentina
Prior art keywords
aminocarbonyl
alkyl
carbamate compounds
independently
compound
Prior art date
Application number
ARP150100575A
Other languages
English (en)
Spanish (es)
Inventor
Kang Young
Soon - Chung Jin
Yong - Maeng Cheol
Young - Yi Han
Ju - Lee Ki
Ho - Heo Joon
Chae Eun
Hee - Shin Yu-Jin
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Publication of AR099581A1 publication Critical patent/AR099581A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/58Y being a hetero atom
    • C07C275/60Y being an oxygen atom, e.g. allophanic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP150100575A 2014-02-28 2015-02-26 Compuestos de aminocarbonilcarbamato AR099581A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461946142P 2014-02-28 2014-02-28

Publications (1)

Publication Number Publication Date
AR099581A1 true AR099581A1 (es) 2016-08-03

Family

ID=54006446

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150100575A AR099581A1 (es) 2014-02-28 2015-02-26 Compuestos de aminocarbonilcarbamato

Country Status (15)

Country Link
US (4) US9403761B2 (enExample)
EP (2) EP3587394B1 (enExample)
JP (2) JP6452731B2 (enExample)
KR (2) KR102309903B1 (enExample)
CN (2) CN109627186B (enExample)
AR (1) AR099581A1 (enExample)
AU (2) AU2015223579B2 (enExample)
CA (1) CA2939835C (enExample)
CL (1) CL2016002165A1 (enExample)
ES (2) ES2968840T3 (enExample)
MX (2) MX387796B (enExample)
PL (1) PL3110792T3 (enExample)
RU (1) RU2688673C2 (enExample)
TW (2) TWI655179B (enExample)
WO (1) WO2015130121A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds
TWI655179B (zh) * 2014-02-28 2019-04-01 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
MY197630A (en) * 2016-09-06 2023-06-29 Sk Biopharmaceuticals Co Ltd Solvate form of (r)-2-amino-3-phenylpropyl carbamate
EP4316592A3 (en) 2016-10-06 2024-05-01 Axsome Malta Ltd. Carbamoyl phenylalaninol compounds and uses thereof
JP2020528075A (ja) 2017-06-02 2020-09-17 ジャズ ファーマシューティカルズ アイルランド リミテッド 過度の眠気を処置するための方法および組成物
CN111153863A (zh) * 2019-12-13 2020-05-15 浙江工业大学 一种合成动物用抗球虫药物妥曲珠利的方法
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
KR102390194B1 (ko) 2020-08-03 2022-04-25 셀라이온바이오메드 주식회사 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
AU674358B2 (en) * 1992-10-28 1996-12-19 Toyama Chemical Co. Ltd. Novel 1,2-benzoisoxazole derivative or its salt and brain -protecting agent comprising the same
KR100197892B1 (ko) 1994-09-09 1999-06-15 남창우 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
KR0173862B1 (ko) * 1995-02-11 1999-04-01 조규향 O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
US5756817C1 (en) 1995-02-11 2001-04-17 Sk Corp O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
KR0173863B1 (ko) 1995-04-10 1999-04-01 조규향 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
WO2004111006A1 (en) 2003-06-12 2004-12-23 Novo Nordisk A/S Para-subtituted phenyl carbamates as inhibitors of hormone sensitive lipase
US20050080268A1 (en) 2003-10-08 2005-04-14 Yong-Moon Choi Process of preparing O-carbamoyl compounds in the presence of active amine group
WO2005042475A2 (en) * 2003-10-21 2005-05-12 Sention, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
WO2006050037A1 (en) 2004-10-28 2006-05-11 Sk Corporation Adjunctive therapy for depression
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
CN101217949B (zh) * 2005-06-08 2012-10-17 爱思开生物制药株式会社 治疗睡眠-清醒病症
CA2612672C (en) 2005-06-22 2014-10-14 Janssen Pharmaceutica, N.V. Treatment for sexual dysfunction
WO2008013860A2 (en) * 2006-07-28 2008-01-31 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of alpha-amino acids, methods of synthesis and use
CN101631770A (zh) * 2007-02-02 2010-01-20 科露西德医药品公司 抑制胆碱酯酶的化合物
CN106727486A (zh) 2009-06-22 2017-05-31 爱思开生物制药株式会社 治疗或预防疲劳的方法
US8232315B2 (en) * 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
RU2557533C2 (ru) 2009-11-06 2015-07-20 Ск Биофармасъютиклс Ко., Лтд. Способы лечения синдрома фибромиалгии
CA2779457C (en) * 2009-11-06 2017-10-17 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
US9610274B2 (en) * 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8623913B2 (en) * 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9226910B2 (en) * 2013-07-18 2016-01-05 Jazz Pharmaceuticals International Iii Limited Treatment for obesity
TWI655179B (zh) * 2014-02-28 2019-04-01 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物

Also Published As

Publication number Publication date
US20180085337A1 (en) 2018-03-29
AU2015223579A1 (en) 2016-08-25
TW201623224A (zh) 2016-07-01
AU2019236666B2 (en) 2021-03-25
US10314808B2 (en) 2019-06-11
AU2015223579B2 (en) 2019-06-27
EP3587394A1 (en) 2020-01-01
PL3110792T3 (pl) 2020-02-28
RU2016136193A3 (enExample) 2018-10-29
US20160303067A1 (en) 2016-10-20
EP3110792A1 (en) 2017-01-04
EP3110792A4 (en) 2017-09-27
JP2019059764A (ja) 2019-04-18
RU2019113158A (ru) 2019-06-25
CA2939835A1 (en) 2015-09-03
CN106458866B (zh) 2018-12-07
CL2016002165A1 (es) 2017-06-09
KR102309903B1 (ko) 2021-10-06
RU2688673C2 (ru) 2019-05-22
MX387796B (es) 2025-03-19
WO2015130121A1 (en) 2015-09-03
AU2019236666A1 (en) 2019-10-17
JP6595078B2 (ja) 2019-10-23
TWI698415B (zh) 2020-07-11
TW201920086A (zh) 2019-06-01
US10485781B2 (en) 2019-11-26
US9833432B2 (en) 2017-12-05
MX2016010973A (es) 2016-11-29
KR20160126988A (ko) 2016-11-02
ES2968840T3 (es) 2024-05-14
TWI655179B (zh) 2019-04-01
MX2020003020A (es) 2021-11-11
JP6452731B2 (ja) 2019-01-16
EP3587394B1 (en) 2023-11-01
US9403761B2 (en) 2016-08-02
CN106458866A (zh) 2017-02-22
CN109627186A (zh) 2019-04-16
KR102487051B1 (ko) 2023-01-09
EP3110792B1 (en) 2019-09-04
CN109627186B (zh) 2021-10-29
ES2759312T3 (es) 2020-05-08
JP2017512211A (ja) 2017-05-18
KR20210124520A (ko) 2021-10-14
US20190247356A1 (en) 2019-08-15
RU2016136193A (ru) 2018-03-30
CA2939835C (en) 2022-11-01
US20150246874A1 (en) 2015-09-03

Similar Documents

Publication Publication Date Title
AR099581A1 (es) Compuestos de aminocarbonilcarbamato
BR112017006253A2 (pt) novos compostos
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
ECSP16082790A (es) Composición de control de enfermedades de plantas y método para controlar enfermedades de plantas mediante su aplicación
MX2017001980A (es) Derivado de quinolina muy puro y metodo para su produccion.
EA201791444A1 (ru) 5-фтор-4-имино-3-(алкил/замещенный алкил)-1-(арилсульфонил)-3,4-дигидропиримидин-2(1h)-он в качестве средства обработки семян
AR093759A1 (es) Dihidropiridona p1 como inhibidores del factor xia
CU20160188A7 (es) Compuestos de indazole substituidos como inhibidores de irak4
MY192603A (en) 1,3-benzodioxole derivative
MX383928B (es) Derivado de piridona que tiene un grupo tetrahidropiranilmetilo.
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
EA201892682A1 (ru) Пестицидные композиции
ECSP17054980A (es) Inhibidores selectivos de bace1
MX2016007861A (es) Compuestos de ácido dimetilbenzoico.
CO2019004978A2 (es) Compuestos terapéuticos y métodos para utilizarlos
EA201691150A1 (ru) Соединения изопропилтриазолопиридина
AR095523A1 (es) Derivados piridin-4-ilo
EA201591915A1 (ru) Соединения феноксиэтил дигидро-1h-изохинолина
MX2016016479A (es) Metodo para producir un pentapeptido sintetico.
AR105821A1 (es) COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T
CO2017001389A2 (es) Compuestos de azetidiniloxifenilpirrolidina
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
MX2020004842A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
EA201692140A1 (ru) Производные аминопиридина в качестве ингибиторов фосфатидилинозитол 3-киназы
EA201690908A1 (ru) Пиразолопиримидиновые соединения

Legal Events

Date Code Title Description
FG Grant, registration